| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |